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MicroRNAs (miRNAs) are small, non-coding, single stranded RNA molecules (19-24 nucleotides in 
length) that influence mRNA or protein levels by promoting either mRNA degradation or by 
preventing protein translation. In silico target prediction has revealed that they might regulate more 
than two thirds of human genes therefore playing an important role in physiological as well as 
pathophysiological processes (Ambros 2004; Lim, Lau et al. 2005). As such miRNAs have been 
identified as mediators of biological processes such as inflammation, angiogenesis, mitochondrial 
metabolism, cardiac and skeletal muscle contractile force generation and muscle hypertrophy  and are 
suggested to play a significant role in exercise immunology by influenceing important immunological 
pathways such as the Nf-κB or the TGF-β signaling pathways (Wessner, Gryadunov-Masutti et al. 
2010; Bronevetsky and Ansel 2013)  
Besides their functional role within cells, significant levels of miRNAs were detected in serum and 
other body fluids such as plasma, saliva, and urine. In serum they are remarkably stable due to their 
association with RNA-binding proteins, exosomes or HDL. Given this stability and the fact that the 
expressions of certain miRNAs are linked to specific tissues, expectations for the use of circulating 
miRNA as non-invasive biomarkers for the diagnosis, prognosis and therapeutic appraisal of diseases 
such as cancer, cardiac failure, diabetes mellitus, acute hepatitis but also inflammageing and muscle 
damage after intense exercise are raised (Olivieri, Spazzafumo et al. 2012; Weiland, Gao et al. 2012)  
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